Catalyst
Slingshot members are tracking this event:
Data from Biogen's (BIIB) Raxatrigine - BIIB074 (Nav1.7 inhibitor) in Painful Lumbosacral Radiculopathy (PLSR) due in 2018
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| BIIB | Community voting in process | |||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Aug 15, 2018
Occurred Source:
https://clinicaltrials.gov/ct2/show/NCT02935608
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Raxatrigine, Biib074, Painful Lumbosacral Radiculopathy
